HIV Drug Discovery and Research

The development of drugs for HIV infection began soon after the virus was discovered 25 years ago. Since then, progress has been substantial, but numerous uncertainties persist about the best way to manage this disease. Here we review the current treatment options, consider novel mechanisms that can be exploited for existing drug targets, and explore the potential of novel targets. With a view to the next quarter century, we consider whether drug resistance can be avoided, which drug classes will be favoured over others, which strategies are most likely to succeed, and the potential impact of pharmacogenomics and individualized therapy.

  • Classes of drugs and mechanism
  • Immunology and strategies towards HIV and retroviral infections
  • HIV/AIDS and STDs/STIs: Vaccines research and development
  • Nucleoside analogues and molecular mechanisms
  • HIV: Current pharmaceutical design

Related Conference of HIV Drug Discovery and Research

June 17-18, 2019

9th World Congress on Rare Diseases and Orphan Drugs

| Berlin, Germany

Venue : Golden Tulip Berlin - Hotel Hamburg

July 29-30, 2019

Annual Meeting on Infectious Diseases

Amsterdam, Netherlands
September 09-10, 2019

12th Global Infections Conference

Singapore
September 23-24, 2019

11th Euro-Global Conference on Infectious Diseases

London, UK
October 21-22, 2019

5th Annual Congress on Infectious Diseases

Frankfurt, Germany
October 21-22, 2019

15th World Congress on Infection Prevention and Control

Zurich, Switzerland
November 18-19, 2019

7th Annual Conference on Parasitology & Infectious Diseases

Johannesburg, South Africa
November 28-29, 2019

2nd World Congress on Rare Diseases

Helsinki, Finland
December 02-03, 2019

5thInternational Conference on HIV and AIDS Research

Barcelona, Spain
Feb 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany

HIV Drug Discovery and Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in